Login / Signup

Prediction-based highly sensitive CRISPR off-target validation using target-specific DNA enrichment.

Seung-Hun KangWi-Jae LeeJu-Hyun AnJong-Hee LeeYoung-Hyun KimHanseop KimYeounsun OhYoung-Ho ParkYeung Bae JinBong-Hyun JunJunho K HurSun-Uk KimSeung Hwan Lee
Published in: Nature communications (2020)
CRISPR effectors, which comprise a CRISPR-Cas protein and a guide (g)RNA derived from the bacterial immune system, are widely used for target-specific genome editing. When the gRNA recognizes genomic loci with sequences that are similar to the target, deleterious mutations can occur. Off-target mutations with a frequency below 0.5% remain mostly undetected by current genome-wide off-target detection techniques. Here we report a method to effectively detect extremely small amounts of mutated DNA based on predicted off-target-specific amplification. In this study, we used various genome editors to induce intracellular genome mutations, and the CRISPR amplification method detected off-target mutations at a significantly higher rate (1.6~984 fold increase) than an existing targeted amplicon sequencing method. In the near future, CRISPR amplification in combination with genome-wide off-target detection methods will allow detection of genome editor-induced off-target mutations with high sensitivity and in a non-biased manner.
Keyphrases
  • genome wide
  • crispr cas
  • genome editing
  • copy number
  • gene expression
  • single cell
  • drug delivery
  • cancer therapy
  • liquid chromatography
  • high glucose
  • circulating tumor
  • binding protein